Cargando…

Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study

BACKGROUND: Anticoagulation with warfarin should be stopped 4–6 days before invasive procedures to avoid bleeding complications. Despite this routine, some patients still have high International Normalized Ratio (INR) values on the day of surgery and the procedure may be cancelled. We sought to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulman, Sam, Elbazi, Rajae, Zondag, Michelle, O'Donnell, Martin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Original Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586623/ https://www.ncbi.nlm.nih.gov/pubmed/18925967 http://dx.doi.org/10.1186/1477-9560-6-15

Ejemplares similares

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Extreme Elevation of the Prothrombin Time-International Normalized Ratio due to a Probable Interaction between Warfarin and Flutamide
por: Konishi, Yasunobu, et al.
Publicado: (2019)

TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study
por: Dunham, C Michael, et al.
Publicado: (2014)

Prothrombin Time in Normal Indians
por: Braganca, Beatriz M., et al.
Publicado: (1946)

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
por: Skerritt, Conor, et al.
Publicado: (2014)

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
por: Srivastava, Ajay, et al.
Publicado: (2008)

Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer
por: Kitade, Hironori, et al.
Publicado: (2016)

A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
por: Yoshioka, Kaoru, et al.
Publicado: (2017)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
por: Onundarson, Pall T., et al.
Publicado: (2021)

Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
por: Wójcik, Cezary, et al.
Publicado: (2009)

Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding
por: Holt, Tara, et al.
Publicado: (2018)

Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study
por: Margraf, David J., et al.
Publicado: (2020)

A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
por: Sølbeck, Sacha, et al.
Publicado: (2012)

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
por: Go, Alan S., et al.
Publicado: (2022)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Inappropriate combination of warfarin and aspirin
por: Turan, Burak, et al.
Publicado: (2016)

Using highly variable warfarin dosing to identify patients at risk for adverse events
por: Marrast, Lyndonna, et al.
Publicado: (2011)

A super‐geriatric patient with gastrostomy underwent life‐threatening prothrombin time‐international normalized ratio prolongation by warfarin following fasting and antibiotic therapy
por: Saeki, Misa, et al.
Publicado: (2023)

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
por: Chapman, Scott A, et al.
Publicado: (2014)

Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience
por: Mačiukaitienė, Jomantė, et al.
Publicado: (2018)

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
por: Guimarães, Patricia O., et al.
Publicado: (2019)

Safety and efficacy of cryoablation for atrial fibrillation in young patients: A multicenter experience in the 1STOP project
por: Bertaglia, Emanuele, et al.
Publicado: (2022)

Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department
por: Maguire, Michelle, et al.
Publicado: (2019)

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
por: Fonseca, Ana G, et al.
Publicado: (2008)

Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians
por: Nicholls, Stuart G, et al.
Publicado: (2014)

A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes
por: Basit, Abdul, et al.
Publicado: (2020)

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021)

Factors contributing to poor outcome in patients on warfarin receiving 4-factor prothrombin complex concentrate in critically ill
por: Mishra, Ajay Kumar, et al.
Publicado: (2021)

Association between prothrombin time-international normalized ratio and prognosis of post-cardiac arrest patients: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2023)

Factors that influence healing of chronic venous leg ulcers: a retrospective cohort()
por: Scotton, Marilia Formentini, et al.
Publicado: (2014)

Cervical dysplasia after renal transplantation: A retrospective cohort study
por: Bilgi, Ahmet, et al.
Publicado: (2021)

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
por: Teklay, Gebrehiwot, et al.
Publicado: (2014)

Do Herbal Formulas Influence the International Normalized Ratio of Patients Taking Warfarin? A Retrospective Study
por: Lu, Hsu-Yuan, et al.
Publicado: (2015)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
por: Haug, Kari Bente Foss, et al.
Publicado: (2008)

Prothrombin Gene G20210A Mutation in Acute Deep Venous Thrombosis Patients with Poor Response to Warfarin Therapy
por: Attia, F.M, et al.
Publicado: (2009)

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
por: Bordeleau, Simon, et al.
Publicado: (2015)

Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
por: Drone, H, et al.
Publicado: (2015)

Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage
por: Corio, Jessica L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ir16g0k81871l8u7b857cfqros